Protocol
Back to shop
Research use only

Sexual Wellness

PE-22-28

Size
10 mg
Form
Lyophilized powder
Purity
≥ 99% (per COA)
COA
Linked per batch

$85.00

Build a stack of 5+ compounds for 20% off — your protocol totals live in the bench tray, with the research-use-only acknowledgment captured at checkout.

For laboratory research use only · Not for human consumption

Reference data

PE-22-28 is a synthetic heptapeptide derived from the spadin fragment of the sortilin propeptide.

Class
Synthetic heptapeptide (spadin fragment analogue)
Also known as
Spadin analogue · PE 22-28
CAS number
1801959-12-5
Appearance
White to off-white lyophilized powder
Storage
Store lyophilized at -20 °C, protected from light. After reconstitution, keep refrigerated at 2–8 °C.
Reconstitution
Reconstitute with bacteriostatic or sterile water; concentration follows the target volume (see the reconstitution calculator).

Sequence

Gly-Val-Ser-Trp-Gly-Leu-Arg

Authoritative references

Reference data is provided for laboratory identification only. Values are sourced from public chemistry databases; confirm against the batch COA. Not for human or animal use.

Quality & testing

Every batch is independently third-party tested for identity, mass, and purity, and ships with a lot code you can verify. How we test →

Dial it in

Reconstitution Calculator

RUO · lab math
BIOTHRIV2 mL0501005.0U
Concentration

5.00mg/mL

5,000 mcg/mL

Draw to target

5.0units

on a U-100 syringe

Measurement math for laboratory research only. Not dosing guidance, medical advice, or a therapeutic claim.

Product reviews

Ratings reflect product quality — purity, labeling, packaging, reconstitution, and shipping. Research use only.

No reviews yet. Be the first to rate this product.

Sign in to leave a product-quality review.

Pairs well with

Complete the stack

Compounds researchers commonly explore alongside PE-22-28. Build a stack of 5+ distinct compounds and 20% comes off the whole protocol (supplies excluded).

Pairings reflect compounds commonly researched together — not a protocol, combination guidance, or any therapeutic claim. Research use only.